Health Condition 1: H25- Age-related cataract Health Condition 2: null- Patients planned for uncomplicated cataract surgery
Conditions
Interventions
Intervention1: Difluprednate eyedrops: 0.05% Difluprednate eyedrops -used postoperatively - frequency 1 drop four times/ day and gradually tapered over 4 weeks
Intervention2: Loteprednol eyedrops: 0
Sponsors
Department of Ophthalmology
Prof Dr Stephen Sudhakar
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients with immature senile cataract, upto grade 3 nuclear sclerosis
Exclusion criteria
Exclusion criteria: 1. signs of uveitis, intraocular inflammation, macular edema due to previous intraocular surgery in any one of the eyes 2. Patients with diabetes, complicated cataract, nuclear sclerosismore than grade 3 3. patients with intraoperative complications 4. one eyed patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. ocular pain 2. intraocular pressure 3. corneal inflammation 4. anterior chamber inflammation 5.macular thicknessTimepoint: 1. Day 1 2. Day 7 3. Day 14 4. Day 28 postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactAaliya Ambereen
Chettinad Hospital & Research Institute
Outcome results
None listed